New stock news | HaoTe Energy-saving, Shimai Pharmaceutical, etc. are planning to IPO in Hong Kong and have already submitted materials to China Securities Regulatory Commission.

According to the Securities Times app, on November 21, the China Securities Regulatory Commission released a table of domestic companies' overseas issuance of securities and listing record filings (initial public offering and full circulation) (as of November 21, 2025). This week (November 17th-21st), among them, DeMei Pharmaceuticals' record status is supplemental materials; Haote Energy, Simai Pharmaceuticals, Merck Biology, Canopy Robotics, Delphi Technology and other companies are planning to list in Hong Kong IPO and have submitted materials accepted by the China Securities Regulatory Commission; Youbao Online (02429.HK), YaoJie An Kang (02617.HK), Bama Tea (06980.HK), YingTai Medical (01501), and Lianlian Digital (02598) and other companies' stock full circulation materials have been accepted by the China Securities Regulatory Commission.